Invention Grant
- Patent Title: Targeted treatment of leiomyosarcoma
-
Application No.: US15560676Application Date: 2016-04-06
-
Publication No.: US10555951B2Publication Date: 2020-02-11
- Inventor: Karim A. Benhadji , Christophe Massard , Jean-Charles Soria
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: ELI LILLY AND COMPANY
- Current Assignee: ELI LILLY AND COMPANY
- Current Assignee Address: US IN Indianapolis
- Agency: Morrison & Foerster, LLP
- International Application: PCT/US2016/026119 WO 20160406
- International Announcement: WO2016/168014 WO 20161020
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61P35/00
Abstract:
A method and medicament comprising 4,4,4-trifluoro-N-[(1S)-2-[[(7S)-5-(2-hydroxyethyl)-6-oxo-7H-pyrido[2,3-d][3]benzazepin-7-yl]amino]-1-methyl-2-oxo-ethyl]butanamide or a pharmaceutically acceptable salt or hydrate thereof for treating leiomyosarcoma is provided.
Public/Granted literature
- US20180104254A1 TARGETED TREATMENT OF LEIOMYOSARCOMA Public/Granted day:2018-04-19
Information query
